Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

82.63
-2.4800-2.91%
Pre-market: 81.54-1.0900-1.32%05:03 EDT
Volume:3.67M
Turnover:304.54M
Market Cap:11.64B
PE:-36.18
High:87.20
Open:84.65
Low:82.16
Close:85.11
52wk High:95.49
52wk Low:27.94
Shares:140.86M
Float Shares:122.00M
Volume Ratio:2.80
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:25.00
PE(LYR):-6,776.84

Loading ...

Arrowhead Pharmaceuticals : B. Riley Raises Target Price to $123 from $101

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

RBC Raises Price Target on Arrowhead Pharmaceuticals to $100 From $87, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jul 29

Arrowhead Pharmaceuticals : RBC Raises Target Price to $100 from $87

THOMSON REUTERS
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Earning Preview: Arrowhead Pharmaceuticals Q3 revenue is expected to increase by 129%, and institutional views are bullish

Earnings Agent
·
Jul 29

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 Yosemite Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia

THOMSON REUTERS
·
Jul 27

Arrowhead Pharmaceuticals - Yosemite Phase 3 Study Completion Anticipated in Mid-2027

THOMSON REUTERS
·
Jul 27

Arrowhead Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 27

Arrowhead price target raised to $126 from $110 at Piper Sandler

TIPRANKS
·
Jul 23

Arrowhead Pharmaceuticals (ARWR) Is Up 23.5% After Strong Plozasiran Phase 3 Data in Severe Hypertriglyceridemia

Simply Wall St.
·
Jul 23

U.S. Research Roundup-alphabet, IBM, Tesla

Reuters
·
Jul 23

Arrowhead Pharmaceuticals : Piper Sandler Raises Target Price to $126 from $110

THOMSON REUTERS
·
Jul 23

NASDAQ Net Change Percentage Gainers & Losers

Dow Jones
·
Jul 23

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live
·
Jul 23

Arrowhead Pharmaceuticals is Maintained at Buy by Chardan Capital

Dow Jones
·
Jul 23

Top Midday Gainers

MT Newswires Live
·
Jul 23

Arrowhead Pharma Shares Rise After Positive Results for Triglyceride Drug Plozasiran Trials

Dow Jones
·
Jul 23

Arrowhead price target raised to $115 from $90 at Chardan

TIPRANKS
·
Jul 23

Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results

TIPRANKS
·
Jul 23